SQSTM1 and breast cancer: Consistently, western blot analysis further revealed decreased expression of ATG, a reduced ratio of LC3-II to LC3-I, and increased SQSTM1 in breast cancer cells with TRPV2 knockdown (Fig. 4G-I).